Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease

American Journal of Geriatric Psychiatry

Volumn 22, Issue 12, 2014, Pages 1642-1651

  Donovan, Nancy J ^a,b   Amariglio, Rebecca E ^a,b   Zoller, Amy S ^b   Rudel, Rebecca K ^b   Gomez Isla, Teresa ^b   Blacker, Deborah ^b   Hyman, Bradley T ^b   Locascio, Joseph J ^b   Johnson, Keith A ^a,b   Sperling, Reisa A ^a,b   Marshall, Gad A ^a,b   Rentz, Dorene M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer disease; mild cognitive impairment; NNeuropsychiatric and neuropsychological factors; subjective cognitive concerns

Indexed keywords

ANTIDEPRESSANT AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; COGNITION; COHORT ANALYSIS; DEPRESSION; DISEASE COURSE; EXECUTIVE FUNCTION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; MOOD DISORDER; NEUROPSYCHOLOGICAL TEST; PROPORTIONAL HAZARDS MODEL; PSYCHOSIS; SEMANTICS; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOLOGY; RISK; SELF EVALUATION; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DIAGNOSTIC SELF EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MASSACHUSETTS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK;

EID: 84928206185     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2014.02.007     Document Type: Article

References (49)

1. Sperling RA, Aisen PS, Beckett LA, et al: Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheim Dement 2011; 7:280-292
2. Reisberg B, Gauthier S: Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Int Psychogeriatr 2008; 20:1-16
3. Storandt M, Grant EA, Miller JP, et al: Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology 2006; 67:467-473
4. Duara R, Loewenstein DA, Greig MT, et al: Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates. Am J Geriatr Psychiatry 2011; 19:951-960
5. Amariglio RE, Becker JA, Carmasin J, et al: Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia 2012; 50:2880-2886
6. Peter J, Scheef L, Abdulkadir A, et al: Gray matter atrophy pattern in elderly with subjective memory impairment. Alzheim Dement 2013; 10:99-108
7. van Harten AC, Visser PJ, Pijnenburg YA, et al: Cerebrospinal fluid Abeta42 is the best predictor of clinical progression in patients with subjective complaints. Alzheim Dement 2013; 9:481-487
8. Gifford KA, Liu D, Lu Z, et al: The source of cognitive complaints predicts diagnostic conversion differentially among nondemented older adults. Alzheimers Dement 2014; 10:319-327
9. Wilson RS, Barnes LL, Mendes de Leon CF, et al: Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002; 59:364-370
10. Yaffe K, Blackwell T, Gore R, et al: Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch Gen Psychiatry 1999; 56:425-430
11. Lyness JM, Kim J, Tang W, et al: The clinical significance of subsyndromal depression in older primary care patients. Am J Geriatr Psychiatry 2007; 15:214-223
12. Pomara N, Bruno D, Sarreal AS, et al: Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. Am J Psychiatry 2012; 169:523-530
13. Lee GJ, Lu PH, Hua X, et al: Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Biol Psychiatry 2012; 71:814-821
14. Wang L, Potter GG, Krishnan RK, et al: Neural correlates associated with cognitive decline in late-life depression. Am J Geriatr Psychiatry 2012; 20:653-663
15. Geda YE, Knopman DS, Mrazek DA, et al: Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol 2006; 63:435-440
16. Barnes DE, Alexopoulos GS, Lopez OL, et al: Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006; 63:273-279
17. Becker JT, Chang YF, Lopez OL, et al: Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry 2009; 17:653-663
18. Wadsworth LP, Lorius N, Donovan NJ, et al: Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. Dement Geriatr Cogn Disord 2012; 34:96-111
19. Slavin MJ, Brodaty H, Kochan NA, et al: Prevalence and predictors of "subjective cognitive complaints" in the Sydney Memory and Ageing Study. Am J Geriatr Psychiatry 2010; 18:701-710
20. Mewton L, Sachdev P, Anderson T, et al: Demographic, clinical, and lifestyle correlates of subjective memory complaints in the Australian population. Am J Geriatr Psychiatry 2014; 22: 1222-1232
21. Merema MR, Speelman CP, Foster JK, et al: Neuroticism (not depressive symptoms) predicts memory complaints in some community-dwelling older adults. Am J Geriatr Psychiatry 2013; 21:729-736
22. Jorm AF, Christensen H, Korten AE, et al: Memory complaints as a precursor of memory impairment in older people: a longitudinal analysis over 7-8 years. Psychol Med 2001; 31:441-449
23. Snitz BE, Morrow LA, Rodriguez EG, et al: Subjective memory complaints and concurrent memory performance in older patients of primary care providers. J Int Neuropsychol Soc 2008; 14: 1004-1013
24. Luck T, Riedel-Heller SG, Luppa M, et al: Risk factors for incident mild cognitive impairment-results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (Age-CoDe). Acta Psychiatr Scand 2010; 121:260-272
25. Steenland K, Karnes C, Seals R, et al: Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers. J Alzheim Dis 2012; 31:265-275
26. Kukull WA: National Alzheimer's Coordinating Center. Available at: http://www.alz.washington.edu. Accessed August 19, 2013
27. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43:2412-2414
28. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
29. Morris JC, Weintraub S, Chui HC, et al: The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheim Dis Assoc Disord 2006; 20: 210-216
30. Ryan J, Paolo A: A screening procedure for estimating premorbid intelligence in the elderly. Clin Neuropsychol 1992; 6:53-62
31. Weschler D: WMS-R Weschler memory scale revised manual. New York, The Psychological Corporation, Harcourt Brace Jovanovich, 1987
32. Morris JC, Heyman A, Mohs RC, et al: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39:1159-1165
33. Goodglass HKE: The assessment of aphasia and related disorders. Philadelphia, Lee & Ferbiger, 1983
34. Wechsler D: Manual: Wechsler memory scale. New York, Psychological Corporation, 1973
35. Reitan RM: Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958; 8:271-276
36. Weschler D: WAIS-R manual. New York, The Psychological Corporation, 1981
37. Kaufer DI, Cummings JL, Ketchel P, et al: Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000; 12:233-239
38. Palmer K, Berger AK, Monastero R, et al: Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 2007; 68:1596-1602
39. Palmer K, Di Iulio F, Varsi AE, et al: Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy. J Alzheim Dis 2010; 20:175-183
40. Rosenberg PB, Mielke MM, Appleby BS, et al: The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry 2013; 21: 685-695
41. Sheline YI, Pieper CF, Barch DM, et al: Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 2010; 67:277-285
42. Sheline YI, Wang PW, Gado MH, et al: Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996; 93: 3908-3913
43. Sturm VE, Yokoyama JS, Seeley WW, et al: Heightened emotional contagion in mild cognitive impairment and Alzheimer's disease is associated with temporal lobe degeneration. Proc Natl Acad Sci USA 2013; 110:9944-9949
44. Byers AL, Yaffe K: Depression and risk of developing dementia. Nat Rev Neurol 2011; 7:323-331
45. Blacker D, Lee H, Muzikansky A, et al: Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol 2007; 64:862-871
46. Dickerson BC, Sperling RA, Hyman BT, et al: Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry 2007; 64:1443-1450
47. Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, et al: Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. Arch Gen Psychiatry 2011; 68:961-969
48. Johnson JK, Gross AL, Pa J, et al: Longitudinal change in neuropsychological performance using latent growth models: a study of mild cognitive impairment. Brain Imaging Behav 2012; 6: 540-550
49. Jessen F, Wolfsgruber S, Wiese B, et al: AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheim Dement 2014; 10:76-83